|
Printable version |
From: | "G Stolwyk" <stolwyk@wave.co.nz> |
Date: | Sun, 7 Oct 2001 20:31:21 +1300 |
Jeremy,
There is a significant product differentiaton. You
listed them in your previous post! And it is blatantly stated in the literature.
Destruction of blood platelets is the greatest fear of surgeons who
implant today's devices.
Anyway, the purpose of my post was to inform the
Holders of MMD shares. They asked me to do so.
And yes, when there is more news, I shall inform them again in a
post.
Gerry
|
Replies
|